BridgeBio Pharma Inc (BBIO) stock news · rev $502.1M
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
This BBIO news page leads with what BridgeBio Pharma Inc filed — not a scraped headline mill.
No cached 8-K sentence for BBIO yet. We will not pad this page with generic market recap.
Latest reported BBIO revenue for 2025-12-31 was $502.1M. Net income was -$732.9M. Revenue was up 126.3% from 2024-12-31 to 2025-12-31. BBIO currently screens at market cap $13.24B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BBIO stock page; for the tape open the quote page.
BBIO stock news FAQ
What are BBIO's latest revenue and net income?
Latest cached BridgeBio Pharma Inc (BBIO) revenue for Dec 31, 2025 was $502.1M. Net income was -$732.9M. Statements: https://lician.com/financials/bbio
How did BBIO revenue change from the prior cached period?
Cached BridgeBio Pharma Inc (BBIO) revenue was up 126.3% from $221.9M (Dec 31, 2024) to $502.1M (Dec 31, 2025). Statements: https://lician.com/financials/bbio
What is BBIO's market cap?
BridgeBio Pharma Inc (BBIO) market cap is $13.24B on the latest cached fundamentals snapshot.
What kind of company is BBIO?
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Where is BBIO stock news listed?
Cached stock news for BridgeBio Pharma Inc (BBIO) is listed at https://lician.com/news/bbio. Filings: https://lician.com/sec/bbio
Not investment advice.